おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Teclison
company
About
Teclison is to develop new drugs to treat cancer and other diseases with strong unmet medical needs.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $5.90M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2014
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Teclison is to develop new drugs to treat cancer and other diseases with strong unmet medical needs.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$5.90M
Teclison has raised a total of
$5.90M
in funding over 2 rounds. Their latest funding was raised on
Feb 14, 2022 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 14, 2022 | Series Unknown | $5.90M | 2 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Teclison is funded by 2 investors.
WTT Investment
and Nestor Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series Unknown |
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
